tradingkey.logo

Treace Medical Concepts Inc

TMCI
2.420USD
-0.020-0.82%
收盘 12/26, 16:00美东报价延迟15分钟
154.17M总市值
亏损市盈率 TTM

Treace Medical Concepts Inc

2.420
-0.020-0.82%

关于 Treace Medical Concepts Inc 公司

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Treace Medical Concepts Inc简介

公司代码TMCI
公司名称Treace Medical Concepts Inc
上市日期Apr 23, 2021
CEOTreace (John T)
员工数量477
证券类型Ordinary Share
年结日Apr 23
公司地址100 Palmetto Park Place
城市PONTE VEDRA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32081
电话19043735940
网址https://www.treace.com/
公司代码TMCI
上市日期Apr 23, 2021
CEOTreace (John T)

Treace Medical Concepts Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+4.86%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
62.40K
-0.33%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+140.86%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
25.00K
-6.14%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月25日 周二
更新时间: 11月25日 周二
持股股东
股东类型
持股股东
持股股东
占比
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
其他
56.62%
持股股东
持股股东
占比
Treace (John T.)
18.37%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
4.29%
其他
56.62%
股东类型
持股股东
占比
Individual Investor
25.43%
Investment Advisor/Hedge Fund
23.25%
Hedge Fund
18.89%
Investment Advisor
16.47%
Research Firm
2.22%
Bank and Trust
0.31%
Pension Fund
0.04%
Family Office
0.03%
Insurance Company
0.03%
其他
13.33%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
2023Q2
290
57.64M
94.33%
-3.44M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Treace (John T.)
11.70M
18.53%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.26M
9.91%
+49.00K
+0.79%
Jun 30, 2025
William Blair Investment Management, LLC
3.10M
4.91%
+39.28K
+1.28%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.28M
5.2%
-119.04K
-3.50%
Jun 30, 2025
The Vanguard Group, Inc.
2.73M
4.31%
+20.22K
+0.75%
Jun 30, 2025
Gagnon Securities LLC
2.25M
3.56%
-459.82K
-16.97%
Jun 30, 2025
Treace (James T)
1.78M
2.82%
--
--
Mar 24, 2025
Millennium Management LLC
1.52M
2.4%
+1.07M
+241.03%
Jun 30, 2025
CIBC Private Wealth Management
1.69M
2.67%
-606.00K
-26.42%
Jun 30, 2025
First Eagle Investment Management, L.L.C.
908.03K
1.44%
+409.11K
+82.00%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
查看更多
iShares U.S. Medical Devices ETF
占比0.04%
Franklin US Small Cap Multifactor Index ETF
占比0.04%
iShares Russell 2000 Growth ETF
占比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
Schwab U.S. Small-Cap ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
Fidelity Enhanced Small Cap ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
iShares Morningstar Small-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Treace Medical Concepts Inc的前五大股东是谁?

Treace Medical Concepts Inc 的前五大股东如下:
Treace (John T.)持有股份:11.70M,占总股份比例:18.53%。
Armistice Capital LLC持有股份:6.26M,占总股份比例:9.91%。
William Blair Investment Management, LLC持有股份:3.10M,占总股份比例:4.91%。
BlackRock Institutional Trust Company, N.A.持有股份:3.28M,占总股份比例:5.20%。
The Vanguard Group, Inc.持有股份:2.73M,占总股份比例:4.31%。

Treace Medical Concepts Inc的前三大股东类型是什么?

Treace Medical Concepts Inc 的前三大股东类型分别是:
Treace (John T.)
Armistice Capital LLC
William Blair Investment Management, LLC

有多少机构持有Treace Medical Concepts Inc(TMCI)的股份?

截至2025Q3,共有338家机构持有Treace Medical Concepts Inc的股份,合计持有的股份价值约为38.30M,占公司总股份的60.11%。与2025Q2相比,机构持股有所增加,增幅为-27.77%。

哪个业务部门对Treace Medical Concepts Inc的收入贡献最大?

在--,--业务部门对Treace Medical Concepts Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI